S. Oertel

发表

Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas

J. Debus, M. Bischof, S. Combs, 2008, Journal of Neuro-Oncology.

Intraoperative radiotherapy for rectal carcinoma.

J. Debus, J. Weitz, M. Bischof, 2005, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.

S. Oertel, J. Krayenbuehl, I. Ciernik, 2007, International journal of radiation oncology, biology, physics.

Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer.

J. Debus, J. Weitz, W. Harms, 2007, International journal of radiation oncology, biology, physics.

Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer.

J. Debus, J. Weitz, M. Eble, 2006, International journal of radiation oncology, biology, physics.

Intraoperative electron radiotherapy for the management of aggressive fibromatosis.

J. Debus, J. Weitz, M. Bischof, 2007, International journal of radiation oncology, biology, physics.

In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model

W. Weichert, A. Stenzinger, U. Haberkorn, 2012, Radiation oncology.

Long term outcome of adolescent and adult patients with pineal parenchymal tumors treated with fractionated radiotherapy between 1982 and 2003 -- a single institution's experience

K. Herfarth, J. Debus, P. Huber, 2010, Radiation oncology.

Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines

J. Debus, M. Bischof, K. Weber, 2011, Radiation oncology.

Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation

J. Debus, K. Weber, A. Kulozik, 2012, Strahlentherapie und Onkologie.

Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy

W. Weichert, A. Stenzinger, J. Debus, 2015, Radiation Oncology.

Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model

W. Weichert, A. Stenzinger, J. Debus, 2013, Strahlentherapie und Onkologie.

The role of combined ion-beam radiotherapy (CIBRT) with protons and carbon ions in a multimodal treatment strategy of inoperable osteosarcoma.

K. Herfarth, U. Haberkorn, J. Debus, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma.

J. Debus, J. Weitz, W. Harms, 2006, International journal of radiation oncology, biology, physics.

Intraoperative electron boost radiation followed by moderate doses of external beam radiotherapy in limb-sparing treatment of patients with extremity soft-tissue sarcoma.

J. Debus, J. Weitz, P. Huber, 2006, International journal of radiation oncology, biology, physics.

Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma

A. Unterberg, J. Debus, M. Bischof, 2010, BMC Cancer.

Human Glioblastoma and Carcinoma Xenograft Tumors Treated by Combined Radiation and Imatinib (Gleevec®)

J. Debus, A. Abdollahi, M. Bischof, 2006, Strahlentherapie und Onkologie.

Radiotherapy in the Treatment of Primary Osteosarcoma – a Single Center Experience

J. Debus, M. Bischof, P. Huber, 2010, Tumori.

The effect of endorectal balloon on anorectal dose during postoperative volumetric arc radiotherapy of prostate cancer.

O. Riesterer, S. Oertel, Y. Najafi, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Intraoperative radiotherapy--special focus: recurrent rectal carcinoma.

T. Lehnert, J. Debus, M. Bischof, 2004, Frontiers of radiation therapy and oncology.

Total Body Irradiation (TBI) in Pediatric Patients

S. Oertel, J. Bourquin, L. Negretti, 2010, Strahlentherapie und Onkologie.

Fatal Clostridium septicum Infection in a Patient with Non-Hodgkin’s Lymphoma Undergoing Multimodal Oncologic Therapy

J. Debus, U. Krautter, S. Oertel, 2009, Oncology Research and Treatment.

A Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma

M. Koch, J. Debus, J. Weitz, 2012, BMC Cancer.

Combination of external-beam radiotherapy with intraoperative electron-beam therapy is effective in incompletely resected pediatric malignancies.

J. Debus, M. Eble, P. Huber, 2006, International journal of radiation oncology, biology, physics.

In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model

W. Weichert, A. Stenzinger, U. Haberkorn, 2012, Radiation oncology.

Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition.

J. Debus, O. Witt, M. Bischof, 2010, International journal of radiation oncology, biology, physics.

Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data

Oliver Jäkel, Susanne Oertel, Jürgen Debus, 2012, Radiation oncology.

Prophylaxis of Heterotopic Ossification in Patients Sedated after Polytrauma

S. Oertel, M. Keel, U. Lütolf, 2008, Strahlentherapie und Onkologie.

Heidelberg Ion Therapy Center (HIT): Initial clinical experience in the first 80 patients

Katia Parodi, Oliver Jäkel, Thomas Haberer, 2010, Acta oncologica.

Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy

W. Weichert, A. Stenzinger, J. Debus, 2015, Radiation oncology.